Year Established :
2005
Total Assets(USD) :
More than 99,999,999
Total Number of Staff :
100-500
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Reputation,Quality Service
Other Competitive Advantages :
Process Capability :
Sartort Biopharma's chemists are skilled at performing complex, multi-step syntheses and producing and sell unique chemicals around the world.
1, we are able to concentracted size and low overheads, we are able to offer prompt quotations, very competitive prices, high quality products and fast delivery.
2, All chemicals are typically >97%. For building blocks, The structure and purity is confirmed by NMR and LC-MS. Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorpting analysis and crystallographical methods.
Business Type :
Trading Company,Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
More than 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Product Range :
APIs&Intermediates，Fine chemicals，Ionic liquids and 3D printing materials
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
